window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us
Veeva Systems Leaderboard Advert
DP Magazine HomeDebbie2025-10-10T16:39:02+01:00
Top News
Jun 18: Wellcome Genome Campus expands AI and genomics ambitions with new advisory group
Jun 18: Microbial manufacturing enters a new era of scale and complexity
Jun 18: AMM and SRT partner to expand ASCENT 2026 RNA therapeutics programme
Jun 18: Resolution Therapeutics expands regenerative macrophage pipeline with in vivo mRNA programme
Jun 18: Gesynta reaches halfway point in Phase 2 endometriosis trial
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Gesynta reaches halfway point in Phase 2 endometriosis trial

    By Liza Laws|Last Updated: 18 June 2026|
  • Digital & Data,Genomics and sequencing

    Wellcome Genome Campus expands AI and genomics ambitions with new advisory group

  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Microbial manufacturing enters a new era of scale and complexity

top headlines

  • Advanced Therapies,Opinion & Events

    AMM and SRT partner to expand ASCENT 2026 RNA therapeutics programme

    The Alliance for mRNA Medicines (AMM) and the Society for [...]

    June 18, 2026
  • Advanced Therapies,Drug Discovery & Development,Therapeutic Areas

    Resolution Therapeutics expands regenerative macrophage pipeline with in vivo mRNA programme

    Resolution Therapeutics has expanded its regenerative macrophage therapy pipeline with [...]

    June 18, 2026
related posts
  • Gesynta reaches halfway point in Phase 2 endometriosis trial
    By Liza Laws|Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas|
  • Movianto expands Belgian healthcare logistics hub to 25,000 pallet capacity
    By Liza Laws|Categories: Manufacturing & Supply Chain|
  • Sysmex launches automated Alzheimer’s blood testing platform in Europe
    By Liza Laws|Categories: Digital & Data, Medical devices, Therapeutic Areas|
related posts
  • Rigel completes VEPPANU licensing deal with Arvinas and Pfizer
    By Liza Laws|Categories: Biotech & Pharma Business|
  • Cystic Fibrosis Foundation backs SpliSense with up to $13m to advance SPL84 Phase 2b study
    By Liza Laws|Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas|
  • Mabion revives MabionCD20 through rare disease collaboration with Oddifact
    By Liza Laws|Categories: Biotech & Pharma Business, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas|

Movers & Shakers

  • Allucent adds strategy leaders to expand therapeutic expertise
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • Genmab appoints Margarida Duarte as general manager for Europe and emerging markets
    Categories: Biotech & Pharma Business, Pharmaceuticals and therapeutics
  • Opella appoints former Reckitt executive Gonzalo Balcazar to lead Europe and Latin America
    Categories: Biotech & Pharma Business, Pharmaceuticals and therapeutics
  • Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Aravax adds allergy specialists to board as peanut therapy advances
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Therapeutic Areas

sponsored content

Biotech & Pharma Business,Digital & Data

Turning AI Skeptics into AI Advocates Through High-Integrity Data

With 89% of AI pilots failing to scale, biopharmas can [...]

continue readingcontinue reading
Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

SGD Pharma highlights GLP-1 demand, supply chain pressure and sustainability focus at DCAT Week

Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]

continue readingcontinue reading
Clinical & Regulatory,Therapeutic Areas

Rare Disease Day 2026: Cereno Scientific advances disease-modifying therapies in PAH

As Rare Disease Day 2026 shines a spotlight on patients [...]

continue readingcontinue reading
Therapeutic Areas

Rare Disease Day 2026: Er-Kim pushes to close access gap in underserved markets

As Rare Disease Day 2026 highlights the challenges faced by [...]

continue readingcontinue reading

Other news

  • Manufacturing & Supply Chain

    Movianto expands Belgian healthcare logistics hub to 25,000 pallet capacity

    Movianto, part of Yusen Logistics, has expanded its healthcare logistics [...]

    read more
  • Digital & Data,Medical devices,Therapeutic Areas

    Sysmex launches automated Alzheimer’s blood testing platform in Europe

    Sysmex Europe has launched its HISCL automated immunoassay platform for [...]

    read more
  • Biotech & Pharma Business

    Rigel completes VEPPANU licensing deal with Arvinas and Pfizer

    Rigel Pharmaceuticals has completed its previously announced licensing agreement with [...]

    read more
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Mabion revives MabionCD20 through rare disease collaboration with Oddifact

    Mabion has signed a letter of intent with French technology [...]

    read more
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Innovative Molecules adds Epstein-Barr virus antiviral programme to pipeline

    Innovative Molecules has expanded its virology pipeline with a new [...]

    read more
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics

    Poolbeg secures European patent decision for POLB 001 in cytokine release syndrome

    Poolbeg Pharma has received a decision to grant a European [...]

    read more
Mail Icon

news via inbox

Sign up for our newsletter and get the latest news right in your inbox

SUBSCRIBE

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Poolbeg secures European patent decision for POLB 001 in cytokine release syndrome
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics
  • Confo Therapeutics reports preclinical data for post-bariatric hypoglycaemia candidate at ENDO 2026
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • CERo Therapeutics reports Phase 1 CER-1236 update with AML patient proceeding to stem cell transplant
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top